跳至主要内容
临床试验/EUCTR2006-004419-24-GB
EUCTR2006-004419-24-GB进行中(未招募)不适用

The Use of Sulfasalazine as an Anti-fibrotic in Acute Alcoholic Hepatitis - SZP in alcoholic hepatitis

Southampton University Hospitals Trust (R&D)0 个研究点开始时间: 2007年1月1日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • All patients will have a diagnosis of acute alcoholic hepatitis based on clinical findings, history of alcohol consumption of >80g/day for men and 60g/day for women and liver histology. Other causes of liver disease will be excluded by standard investigations. The diagnosis of alcoholic hepatitis will be confirmed by liver biopsy prior to trial entry.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Informed consent refused by patient.
  • Clearly moribund patients or patients with evidence of established irreversible triple organ failure in whom survival is extremely unlikely.

研究者

发起方
Southampton University Hospitals Trust (R&D)

相似试验